{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:43:00Z","timestamp":1793209380300,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Open Project of Key Laboratory of Xinjiang Uygur Autonomous Region","award":["KLUMH-202404"],"award-info":[{"award-number":["KLUMH-202404"]}]},{"name":"Tianshan Innovation Team Project","award":["2024D14018"],"award-info":[{"award-number":["2024D14018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160654,81960625"],"award-info":[{"award-number":["82160654,81960625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960625"],"award-info":[{"award-number":["81960625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160654"],"award-info":[{"award-number":["82160654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108639","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:07:38Z","timestamp":1748430458000},"page":"108639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer activity of novel licochalcone A derivatives based on dual targeting of VEGFR-2\/P-gp"],"prefix":"10.1016","volume":"163","author":[{"given":"Zheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourboul","family":"Ablise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikebaier","family":"Maimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuohelaguli","family":"Mutalipu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizitiaili","family":"Aihaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108639_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102339","article-title":"ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy","volume":"53","author":"Fan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0010","article-title":"Cervical Cancer screening practice among women: a community based cross-sectional study design","volume":"60","author":"Tadesse","year":"2023","journal-title":"Inquiry"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108639_bb0015","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ijc.34319","article-title":"Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells","volume":"152","author":"Yao","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108639_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113989","article-title":"Licochalcone a inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-\u03baB and Ras\/Raf\/MEK pathways","volume":"273","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7032614","article-title":"Research Progress and prospects of autophagy in the mechanism of multidrug resistance in tumors","volume":"2022","author":"Long","year":"2022","journal-title":"J. Oncol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108639_bb0030","first-page":"555","article-title":"The lactate receptor (HCAR1\/GPR81) contributes to doxorubicin chemoresistance via ABCB1 transporter up-regulation in human cervical cancer HeLa cells","volume":"68","author":"Wagner","year":"2017","journal-title":"J. Physiol. Pharmacol. : Off. J. Polish Physiol. Soc."},{"key":"10.1016\/j.bioorg.2025.108639_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.colsurfb.2018.09.078","article-title":"Molecular imprinted S-nitrosothiols nanoparticles for nitric oxide control release as cancer target chemotherapy","volume":"173","author":"Liu","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108639_bb0040","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1007\/s13277-014-2463-2","article-title":"Molecular regulation of cervical cancer growth and invasion by VEGFa","volume":"35","author":"Chen","year":"2014","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108639_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2008.04.038","article-title":"Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease","volume":"110","author":"Hammes","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ijbiomac.2022.11.191","article-title":"A sensitive double antibodies sandwich ELISA for the diagnosis and therapeutic evaluation of cervical cancer","volume":"225","author":"Li","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108639_bb0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bcp.2011.02.016","article-title":"The angiogenic process as a therapeutic target in cancer","volume":"81","author":"Bridges","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13065-024-01165-8","article-title":"QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking","volume":"18","author":"Ding","year":"2024","journal-title":"BMC Chem"},{"key":"10.1016\/j.bioorg.2025.108639_bb0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejmech.2017.07.062","article-title":"Overcoming ABC transporter-mediated multidrug resistance: the dual role of tyrosine kinase inhibitors as multitargeting agents","volume":"142","author":"Beretta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108639_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in Cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108639_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jep.2017.01.028","article-title":"Antioxidative and anticancer properties of Licochalcone a from licorice","volume":"198","author":"Chen","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108639_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020684","article-title":"Licochalcone a suppresses renal Cancer cell proliferation and metastasis by engagement of Sp1-mediated LC3 expression","volume":"15","author":"Tseng","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108639_bb0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/bdd.1905","article-title":"Effects of licochalcone a on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone a","volume":"35","author":"Choi","year":"2014","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010090","article-title":"Co-inhibition of P-gp and Hsp90 by an Isatin-derived compound contributes to the increase of the Chemosensitivity of MCF7\/ADR-resistant cells to doxorubicin","volume":"27","author":"Abdalla","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108639_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopha.2015.01.007","article-title":"Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein","volume":"70","author":"Nabekura","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108639_bb0100","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bcp.2010.07.006","article-title":"Antiangiogenic effect of licochalcone a","volume":"80","author":"Kim","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/14756366.2020.1861606","article-title":"Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation","volume":"36","author":"Ahmed","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/138955711793564015","article-title":"Recent progress of small molecular VEGFR inhibitors as anticancer agents","volume":"11","author":"Xu","year":"2011","journal-title":"Mini-Rev. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108639_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2004.07.004","article-title":"Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone a","volume":"39","author":"Kromann","year":"2004","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108639_bb0120","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1016\/j.bmcl.2009.07.054","article-title":"Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B","volume":"19","author":"Yoon","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108639_bb0125","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1016\/j.bmc.2015.08.043","article-title":"Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents","volume":"23","author":"Vergelli","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108639_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/chin.201606196","article-title":"ChemInform abstract: synthesis of 5-Aryl-2-hydroxy-2-(trifluoromethyl)furan-3(2H)-ones and their reactions with aromatic 1,2-diamines, hydrazine and hydroxylamine","volume":"47","author":"Safrygin","year":"2016","journal-title":"ChemInform"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108639_bb0135","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/med.21698","article-title":"Chalcone hybrids as potential anticancer agents: current development, mechanism of action, and structure-activity relationship","volume":"40","author":"Gao","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108639_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2019.05.053","article-title":"Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance","volume":"180","author":"Yin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108639_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"issue":"20","key":"10.1016\/j.bioorg.2025.108639_bb0150","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1016\/j.bmc.2010.08.042","article-title":"N-phenyl-N\u2019-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases","volume":"18","author":"Oguro","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108639_bb0155","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","article-title":"Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth","volume":"10","author":"Yakes","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108639_bb0160","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1021\/jm901913s","article-title":"Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors","volume":"53","author":"Wang","year":"2010","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108639_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102741","article-title":"Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents","volume":"9","author":"Jayanthan","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1349-7006.2009.01343.x","article-title":"E7050: a dual c-met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models","volume":"101","author":"Nakagawa","year":"2010","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108639_bb0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/cas.12409","article-title":"Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor","volume":"105","author":"Nakagawa","year":"2014","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108639_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.apsb.2019.07.007","article-title":"Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents","volume":"10","author":"Feng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108639_bb0185","series-title":"Search for ABCB1 Modulators among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance, Molecules","volume":"vol. 25","author":"Kaczor","year":"2020"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108639_bb0190","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cam4.1282","article-title":"The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer","volume":"7","author":"Nakanishi","year":"2018","journal-title":"Cancer Med."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108639_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2008.06.001","article-title":"Modulation of breast cancer resistance protein (BCRP\/ABCG2) by non-basic chalcone analogues","volume":"35","author":"Han","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108639_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113848","article-title":"Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2\/ABCB1 inhibitor","volume":"175","author":"Cai","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2018.12.019","article-title":"Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2","volume":"164","author":"Silbermann","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108639_bb0210","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bmcl.2011.12.017","article-title":"Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase","volume":"22","author":"Rizvi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108639_bb0215","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1248\/bpb.29.1028","article-title":"Anti-angiogenic and anti-tumor activities of 2\u2032-hydroxy-4\u2032-methoxychalcone","volume":"29","author":"Lee","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108639_bb0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.phytol.2013.03.017","article-title":"Prenylflavone derivatives from Broussonetia papyrifera, inhibit the growth of breast cancer cells in vitro and in vivo - ScienceDirect","volume":"6","author":"Fujiang","year":"2013","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.bioorg.2025.108639_bb0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","article-title":"Anti-cancer chalcones: structural and molecular target perspectives","volume":"98","author":"Mahapatra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108639_bb0230","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.bmcl.2016.10.029","article-title":"Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit","volume":"26","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108639_bb0235","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.bmc.2014.02.028","article-title":"Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108639_bb0240","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/1521-3935(20010601)202:9<1812::AID-MACP1812>3.0.CO;2-W","article-title":"Preparation of Polyarylates from Dihydroxyaceto-phenones by the solution Polycondensation with TsCl\/DMF\/Py as a condensing agent","volume":"202","author":"Higashi","year":"2001","journal-title":"Macromol. Chem. Phys."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108639_bb0245","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.bmc.2011.08.004","article-title":"Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation","volume":"19","author":"Reddy","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0250","first-page":"1","article-title":"Cervical cancer in Ethiopia: a review of the literature","volume":"34","author":"Derbie","year":"2022","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1871520622666220513160706","article-title":"A recent advancement in nanotechnology approaches for the treatment of cervical Cancer","volume":"23","author":"Hegde","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108639_bb0260","series-title":"The MTT Assay: A Method for Error Minimization and Interpretation in Measuring Cytotoxicity and Estimating Cell Viability, Methods in Molecular Biology","first-page":"15","volume":"vol. 2644","author":"Ghasemi","year":"2023"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0265","article-title":"MicroRNA-204 regulates angiogenesis and Vasculogenic mimicry in CD44+\/CD24- breast Cancer stem-like cells","volume":"10","author":"Resendiz-Hern\u00e1ndez","year":"2024","journal-title":"Noncoding RNA"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0270","doi-asserted-by":"crossref","DOI":"10.1677\/ERC-08-0304","article-title":"Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis","volume":"17","author":"Rodr\u00edguez-Antona","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108639_bb0275","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/15384101.2018.1471315","article-title":"Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with paclitaxel","volume":"17","author":"Qiu","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2025.108639_bb0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","article-title":"Prediction of drug-ABC-transporter interaction--Recent advances and future challenges","volume":"86","author":"Montanari","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"27","key":"10.1016\/j.bioorg.2025.108639_bb0285","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2174\/138161212802430530","article-title":"Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspective","volume":"18","author":"Palmeira","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.108639_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114821","article-title":"Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting VHL for the treatment of gastric cancer","volume":"244","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108639_bb0295","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bioorg.2018.10.071","article-title":"Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity","volume":"82","author":"Elsayed","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108639_bb0300","article-title":"Novel VEGFR-2 kinase inhibitors as anticancer agents: a review focusing on SAR and molecular docking studies (2016-2021)","volume":"20","author":"Kajal","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2025.108639_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105105","article-title":"Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: design, synthesis, and anti-proliferative evaluation","volume":"114","author":"El-Adl","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108639_bb0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(03)01277-4","article-title":"Anticancer therapy targeting the apoptotic pathway","volume":"4","author":"Hu","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154854","article-title":"The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors","volume":"251","author":"Almalki","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bioorg.2025.108639_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113192","article-title":"Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors","volume":"213","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108639_bb0325","article-title":"Vascular endothelial growth factor: molecular and biological aspects","volume":"237","author":"Ferrara","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108639_bb0330","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/19420862.2015.1045168","article-title":"TTAC-0001, a human monoclonal antibody targeting VEGFR-2\/KDR, blocks tumor angiogenesis","volume":"7","author":"Lee","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.bioorg.2025.108639_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154591","article-title":"Angiogenesis and prostate cancer: MicroRNAs comes into view","volume":"248","author":"Gupta","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bioorg.2025.108639_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100681","article-title":"Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update","volume":"49","author":"Dong","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2025.108639_bb0345","article-title":"Implication of ABC transporters in non-proliferative diseases","volume":"175327","author":"Grigoreva","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108639_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106324","article-title":"CADD, AI and ML in drug discovery: a comprehensive review","volume":"181","author":"Vemula","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108639_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116039","article-title":"Discovery of (quinazolin-6-yl)benzamide derivatives containing a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety as potent reversal agents against P-glycoprotein-mediated multidrug resistance","volume":"264","author":"Xue","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108639_bb0360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/2472630319891135","article-title":"Using fluid walls for single-cell cloning provides Assurance in Monoclonality","volume":"25","author":"Soitu","year":"2020","journal-title":"SLAS Technol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1208\/s12249-022-02211-1","article-title":"Non-ionic surfactants as a P-glycoprotein(P-gp) efflux inhibitor for optimal drug delivery-a concise outlook","volume":"23","author":"Rathod","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108639_bb0370","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108639_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105696","article-title":"Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors","volume":"121","author":"Zengin","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108639_bb0380","series-title":"Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation, Molecules","volume":"vol. 27","author":"Elwan","year":"2022"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108639_bb0385","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/ijc.34288","article-title":"Out of the cycle: impact of cell cycle aberrations on cancer metabolism and metastasis","volume":"152","author":"Cheung","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108639_bb0390","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41419-023-05704-4","article-title":"Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells","volume":"14","author":"Legrand","year":"2023","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108639_bb0395","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108639_bb0400","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/01480545.2018.1561713","article-title":"Acute and sub-acute toxicity evaluation of the root extract of Rheum turkestanicum Janisch","volume":"43","author":"Jahani Yazdi","year":"2020","journal-title":"Drug Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0405","first-page":"50","article-title":"Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions","volume":"22","author":"Shah","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bioorg.2025.108639_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106425","article-title":"Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy","volume":"133","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0415","doi-asserted-by":"crossref","first-page":"18567","DOI":"10.1038\/s41598-023-45687-y","article-title":"Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2\/c-met-TK inhibitors: design, synthesis, and biological evaluation","volume":"13","author":"Hassan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108639_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106769","article-title":"Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo","volume":"191","author":"Qu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"45","key":"10.1016\/j.bioorg.2025.108639_bb0425","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108639_bb0430","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/acs.jmedchem.1c01272","article-title":"Discovery and characterization of potent dual P-glycoprotein and CYP3A4 inhibitors: design, synthesis, Cryo-EM analysis, and biological evaluations","volume":"65","author":"Urgaonkar","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500519X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500519X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:01:30Z","timestamp":1776920490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500519X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":86,"alternative-id":["S004520682500519X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108639","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer activity of novel licochalcone A derivatives based on dual targeting of VEGFR-2\/P-gp","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108639"}}